Loading…
Reported covered position: Professional Policy Staff, Republican Study Committee 2011-2013; Legislative Asst. to Senator Tim Scott 2013 - 2015; Member Services Staff, House Financial Services Committee 2015; Deputy Asst. and Special Asst. to President Donald Trump 2017-2020
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OTW HOLDINGS LLC via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to maternal and infant health.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
STATE STREET GLOBAL ADVISORS TRUST COMPANY via CGCN GROUP, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| CONSTELLATION BRANDS, INC |
| 9 |
| 2024–2026 |
| BILLMARI INC. / DBA BLACK BLOCKCHAIN SUMMIT | 8 | 2024–2026 |
| CISCO SYSTEMS, INC. | 8 | 2025–2026 |
| ENERGYSOURCE MINERALS (FKA ENERGY SOURCE MINERALS) | 8 | 2025–2026 |
| GLOBALFOUNDRIES U.S. INC. | 8 | 2025–2026 |
| HOWARD UNIVERSITY | 8 | 2025–2026 |
| OPPORTUNITY FUNDS ASSOCIATION | 8 | 2025–2026 |
| THURGOOD MARSHALL COLLEGE FUND | 8 | 2025–2026 |
| UNITED NEGRO COLLEGE FUND | 8 | 2025–2026 |
| BINTI | 7 | 2025–2026 |
| HUNT COMPANIES, INC. | 7 | 2025–2026 |
| MOODY'S CORPORATION | 7 | 2025–2026 |
| NATIONAL COMMUNITY STABILIZATION TRUST | 7 | 2025–2026 |
| POLYMEDCO, LLC. | 7 | 2024–2025 |
| AMERICAN CHEMISTRY COUNCIL, INC. | 6 | 2025–2026 |
| NATIONAL BLACK EMPOWERMENT ACTION FUND | 6 | 2024–2025 |
| PROFESSIONAL BEAUTY ASSOCIATION | 6 | 2024–2025 |
| EXELON CORPORATION | 5 | 2025–2026 |
| MICROSOFT CORPORATION | 5 | 2024–2025 |
| TZEDEK ASSOCIATION | 5 | 2024 |
| CONSENSYS SOFTWARE INC. | 4 | 2025 |
| GENERAL III, LLC D/B/A SOUTHSIDE RECYCLING | 4 | 2025 |
| INFLEQTION INC. | 4 | 2026 |
| KRAFT HEINZ COMPANY | 4 | 2025 |
| TD BANK, N.A. | 4 | 2025–2026 |
| TRUEHOLD | 4 | 2026 |
| GLOBAL PAYMENTS INC. | 3 | 2025 |
| HEARTLAND ACTION | 3 | 2026 |
| OUTSCHOOL, INC. | 3 | 2025 |
| OUTSCHOOL.ORG | 3 | 2025 |
| SOLAR LANDSCAPE | 3 | 2025 |
| STATE STREET GLOBAL ADVISORS TRUST COMPANY | 3 | 2026 |
| HEALTHY MOMS, HEALTHY BABIES AMERICA | 2 | 2026 |
| HOUSING PARTNERSHIP NETWORK | 2 | 2025 |
| ODYSSEY | 2 | 2025 |
| OTW HOLDINGS LLC | 2 | 2026 |
| YMCA OF GREATER CLEVELAND | 2 | 2026 |
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues; S.4668 Protect College Sports Act of 2026 - Title II (Media Rights).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Children and Teens’ Online Privacy Protection Act
Client: THE WALT DISNEY COMPANY · Firm: CGCN GROUP, LLC
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues; S.4668 Protect College Sports Act of 2026 - Title II (Media Rights).
Children and Teens’ Online Privacy Protection Act
Client: THE WALT DISNEY COMPANY · Firm: CGCN GROUP, LLC
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1409: Kids Online Safety Act; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1409: Kids Online Safety Act; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues.
Children and Teens’ Online Privacy Protection Act
Client: THE WALT DISNEY COMPANY · Firm: CGCN GROUP, LLC
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues; S.4668 Protect College Sports Act of 2026 - Title II (Media Rights).
Children and Teens’ Online Privacy Protection Act
Client: THE WALT DISNEY COMPANY · Firm: CGCN GROUP, LLC
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1409: Kids Online Safety Act; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PROFESSIONAL BEAUTY ASSOCIATION · Firm: CGCN GROUP, LLC
S. 1998, H.R. 2603 - Small Business Tax Fairness and Compliance Simplification Act; H.R. 1 - One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PROFESSIONAL BEAUTY ASSOCIATION · Firm: CGCN GROUP, LLC
S. 1998, H.R. 2603 - Small Business Tax Fairness and Compliance Simplification Act; H.R. 1 - One Big Beautiful Bill Act.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY25 and FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY25 and FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY25 and FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY25 and FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC. · Firm: CGCN GROUP, LLC
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Small Business Tax Fairness and Compliance Simplification Act
Client: PROFESSIONAL BEAUTY ASSOCIATION · Firm: CGCN GROUP, LLC
S. 1998, H.R. 2603 - Small Business Tax Fairness and Compliance Simplification Act; H.R. 1 - One Big Beautiful Bill Act.
Small Business Tax Fairness and Compliance Simplification Act
Client: PROFESSIONAL BEAUTY ASSOCIATION · Firm: CGCN GROUP, LLC
S. 1998, H.R. 2603 - Small Business Tax Fairness and Compliance Simplification Act; H.R. 1 - One Big Beautiful Bill Act.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Small Business Tax Fairness and Compliance Simplification Act
Client: PROFESSIONAL BEAUTY ASSOCIATION · Firm: CGCN GROUP, LLC
S. 1998, H.R. 2603 - Small Business Tax Fairness and Compliance Simplification Act; H.R. 1 - One Big Beautiful Bill Act.
Small Business Tax Fairness and Compliance Simplification Act
Client: PROFESSIONAL BEAUTY ASSOCIATION · Firm: CGCN GROUP, LLC
S. 1998, H.R. 2603 - Small Business Tax Fairness and Compliance Simplification Act; H.R. 1 - One Big Beautiful Bill Act.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Issues related to AI (artificial intelligence) in the defense industry; S.4921 - Department ofDefenseAppropriations Act,2025; H.R.8774- Department ofDefenseAppropriations Act,2025.
TRUMP Accounts in Public Law 119-21.
TRUMP Accounts in Public Law 119-21.
TRUMP Accounts in Public Law 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TD BANK, N.A. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to taxes.
Issues related to community development and banking activity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPPORTUNITY FUNDS ASSOCIATION via CGCN GROUP, LLC
2026 · third_quarter · 3A
Issues related to tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOODY'S CORPORATION via CGCN GROUP, LLC
2026 · third_quarter · Q3
Education on economic trends impacting the global economy.
Filing targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CONSTELLATION BRANDS, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Cross-border trade issues.
Commercial issues related to the beverage alcohol industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
C3.AI, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to housing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
HCBS FKA HUNT COMPANIES, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to housing.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
INFLEQTION INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to quantum computing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE, White House Office
AMERICAN CHEMISTRY COUNCIL, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to international agreements on plastic production.
Issues related to the role of chemistry in economy; regulations affecting the chemical industry; rail and distribution issues related to the chemical industry.
Transportation and policies that impact commodity transportation and competition, rates, and reliability.
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
THE WALT DISNEY COMPANY via CGCN GROUP, LLC
2026 · third_quarter · Q3
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues; S.4668 Protect College Sports Act of 2026 - Title II (Media Rights).
Theme park safety and security.
Corporate and production tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NEGRO COLLEGE FUND via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
THURGOOD MARSHALL COLLEGE FUND via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
OPPORTUNITY FUNDS ASSOCIATION via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COMMUNITY STABILIZATION TRUST via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to home ownership.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of, White House Office
HOWARD UNIVERSITY via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
GLOBALFOUNDRIES U.S. INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Monitor issues related to domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
EMERGENT BIOSOLUTIONS INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
CISCO SYSTEMS, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues impacting technology companies.
Issues impacting technology companies.
Issues impacting technology companies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARE SOLACE via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to mental healthcare and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ACTION NOW INITIATIVE, LLC via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to criminal justice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGYSOURCE MINERALS (FKA ENERGY SOURCE MINERALS) via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues on policies that would impact critical mineral processing.
Issues on policies that would impact critical mineral processing.
Issues on policies that would impact critical mineral processing.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
REFORM ACTION FUND via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
OTW HOLDINGS LLC via CGCN GROUP, LLC
2026 · third_quarter · RR
Issues related to maternal and infant health.
HEALTHY MOMS, HEALTHY BABIES AMERICA via CGCN GROUP, LLC
2026 · third_quarter · RA
Issues related to maternal and infant health.
2026 · second_quarter · Q2
Issues related to housing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
2026 · first_quarter · Q1
Issues related to housing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
2026 · first_quarter · RR
Issues related to housing.
HEALTHY MOMS, HEALTHY BABIES AMERICA via CGCN GROUP, LLC
2026 · third_quarter · RR
Issues related to maternal and infant health.
AMERICAN CHEMISTRY COUNCIL, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Transportation and policies that impact commodity transportation and competition, rates, and reliability.
Issues related to international agreements on plastic production.
Issues related to the role of chemistry in economy; regulations affecting the chemical industry; rail and distribution issues related to the chemical industry.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Vice President of the U.S.
MOODY'S CORPORATION via CGCN GROUP, LLC
2026 · second_quarter · Q2
Education on economic trends impacting the global economy.
Filing targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
HEARTLAND ACTION via CGCN GROUP, LLC
2026 · second_quarter · 2T
Issues related to maternal and infant health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELON CORPORATION via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
THE WALT DISNEY COMPANY via CGCN GROUP, LLC
2026 · second_quarter · Q2
Theme park safety and security.
Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1409: Kids Online Safety Act; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0); Sports media issues.
Corporate and production tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TD BANK, N.A. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to community development and banking activity.
Issues related to taxes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
CONSTELLATION BRANDS, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Commercial issues related to the beverage alcohol industry.
Cross-border trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
HCBS FKA HUNT COMPANIES, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to housing.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
INFLEQTION INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to quantum computing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE, White House Office
STATE STREET GLOBAL ADVISORS TRUST COMPANY via CGCN GROUP, LLC
2026 · second_quarter · Q2
TRUMP Accounts in Public Law 119-21.
TRUMP Accounts in Public Law 119-21.
TRUMP Accounts in Public Law 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues impacting technology companies.
Issues impacting technology companies.
Issues impacting technology companies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARE SOLACE via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to mental healthcare and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
C3.AI, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to AI (artificial intelligence) in the defense industry.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
YMCA OF GREATER CLEVELAND via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to funding for new facilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BINTI via CGCN GROUP, LLC
2026 · second_quarter · 2T
Issues regarding child welfare and technology.
Issues regarding child welfare and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
UNITED NEGRO COLLEGE FUND via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
THURGOOD MARSHALL COLLEGE FUND via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
OPPORTUNITY FUNDS ASSOCIATION via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COMMUNITY STABILIZATION TRUST via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to home ownership.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of, White House Office
HOWARD UNIVERSITY via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
GLOBALFOUNDRIES U.S. INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Monitor issues related to domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
ACTION NOW INITIATIVE, LLC via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to criminal justice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGYSOURCE MINERALS (FKA ENERGY SOURCE MINERALS) via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues on policies that would impact critical mineral processing.
Issues on policies that would impact critical mineral processing.
Issues on policies that would impact critical mineral processing.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
REFORM ACTION FUND via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
YMCA OF GREATER CLEVELAND via CGCN GROUP, LLC
2026 · second_quarter · RR
Issues related to funding for new facilities.
INFLEQTION INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to quantum computing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE, White House Office
INFLEQTION INC. via CGCN GROUP, LLC
2026 · first_quarter · RR
Issues related to quantum computing.
STATE STREET GLOBAL ADVISORS TRUST COMPANY via CGCN GROUP, LLC
2026 · second_quarter · RR
TRUMP Accounts in Public Law 119-21
TRUMP Accounts in Public Law 119-21
TRUMP Accounts in Public Law 119-21
HCBS FKA HUNT COMPANIES, INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to housing.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
HEARTLAND ACTION via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to maternal and infant health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBALFOUNDRIES U.S. INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Monitor issues related to domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
HOWARD UNIVERSITY via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
EMERGENT BIOSOLUTIONS INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
OPPORTUNITY FUNDS ASSOCIATION via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFORM ACTION FUND via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
REFORM ACTION FUND via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TD BANK, N.A. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to community development and banking activity.
Issues related to taxes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WALT DISNEY COMPANY via CGCN GROUP, LLC
2026 · first_quarter · Q1
Workplace Benefits, Training and Development.
Issues related to Trade Policy.
Issues related to television streaming.
CONSTELLATION BRANDS, INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Commercial issues related to the beverage alcohol industry.
Cross-border trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CISCO SYSTEMS, INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues impacting technology companies.
Issues impacting technology companies.
Issues impacting technology companies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
C3.AI, INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to AI (artificial intelligence) in the defense industry.
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELON CORPORATION via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
AMERICAN CHEMISTRY COUNCIL, INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to international agreements on plastic production.
Transportation and policies that impact commodity transportation and competition, rates, and reliability.
Issues related to the role of chemistry in economy; regulations affecting the chemical industry; rail and distribution issues related to the chemical industry.
Filing targets: Executive Office of the President (EOP), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Vice President of the U.S.
ENERGYSOURCE MINERALS (FKA ENERGY SOURCE MINERALS) via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues on policies that would impact critical mineral processing.
Issues on policies that would impact critical mineral processing.
Issues on policies that would impact critical mineral processing.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
UNITED NEGRO COLLEGE FUND via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
THURGOOD MARSHALL COLLEGE FUND via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to higher education and Historically Black Colleges and Universities (HBCUs).
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL COMMUNITY STABILIZATION TRUST via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to home ownership.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of, White House Office
MOODY'S CORPORATION via CGCN GROUP, LLC
2026 · first_quarter · Q1
Education on economic trends impacting the global economy.
Filing targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CARE SOLACE via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to mental healthcare and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BINTI via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues regarding child welfare and technology.
Issues regarding child welfare and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BILLMARI INC. / DBA BLACK BLOCKCHAIN SUMMIT via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to blockchain technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACTION NOW INITIATIVE, LLC via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to criminal justice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTLAND ACTION via CGCN GROUP, LLC
2026 · first_quarter · RR
Issues related to maternal health.
EMERGENT BIOSOLUTIONS INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
GLOBALFOUNDRIES U.S. INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Monitor issues related to domestic manufacturing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL PAYMENTS INC. via CGCN GROUP, LLC
2025 · fourth_quarter · 4T
Financial services issues and cyber security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KRAFT HEINZ COMPANY via CGCN GROUP, LLC
2025 · fourth_quarter · 4T
Issues related to food quality, pricing, and ingredients.
Issues related to food quality, pricing, and ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
POLYMEDCO, LLC. via CGCN GROUP, LLC
2025 · fourth_quarter · 4T
Issues related to colorectal cancer screening.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TD BANK, N.A. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to community development and banking activity.
Issues related to taxes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFORM ACTION FUND via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to law enforcement, crime and criminal justice; H.R. 5005: Safer Supervision Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
THE WALT DISNEY COMPANY via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to television streaming.
Issues related to Trade Policy.
Workplace Benefits, Training and Development.
EXELON CORPORATION via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
MOODY'S CORPORATION via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Education on economic trends impacting the global economy.
Filing targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
C3.AI, INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to AI (artificial intelligence) in the defense industry; H.R. 4016 - Department of Defense Appropriations Act, 2026; S. 2572 Department of Defense Appropriations Act, 2026.
Issues related to AI (artificial intelligence) in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGYSOURCE MINERALS (FKA ENERGY SOURCE MINERALS) via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues on policies that would impact mineral processing.
Issues on policies that would impact mineral processing.
Issues on policies that would impact mineral processing.
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HUNT COMPANIES, INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to housing.
Filing targets: Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to the role of chemistry in economy; regulations affecting the chemical industry; rail and distribution issues related to the chemical industry.
Issues related to tax policies that impact the chemical industry.
Issues related to international agreements on plastic production.
Filing targets: Executive Office of the President (EOP), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Vice President of the U.S.
BINTI via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues regarding child welfare and technology.
Issues regarding child welfare and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CARE SOLACE via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to mental healthcare and technology.
Filing targets: Agriculture, Dept of (USDA), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone; H.R. 5252, Having Overdoes Protection Equipment Act; Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Corporate Tax Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 Tribal Opioid Response Grant funding for FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Corporate Tax Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues on policies that would impact the transmission and distribution utility industry.
Issues on policies that would impact the transmission and distribution utility industry.
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, Treasury, Dept of